These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 21596680)

  • 1. Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis.
    Török ME; Yen NT; Chau TT; Mai NT; Phu NH; Mai PP; Dung NT; Chau NV; Bang ND; Tien NA; Minh NH; Hien NQ; Thai PV; Dong DT; Anh DT; Thoa NT; Hai NN; Lan NN; Lan NT; Quy HT; Dung NH; Hien TT; Chinh NT; Simmons CP; de Jong M; Wolbers M; Farrar JJ
    Clin Infect Dis; 2011 Jun; 52(11):1374-83. PubMed ID: 21596680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor prognosis of HIV-associated tuberculous meningitis regardless of the timing of antiretroviral therapy.
    Lawn SD; Wood R
    Clin Infect Dis; 2011 Jun; 52(11):1384-7. PubMed ID: 21596681
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial.
    Arenas-Pinto A; Grund B; Sharma S; Martinez E; Cummins N; Fox J; Klingman KL; Sedlacek D; Collins S; Flynn PM; Chasanov WM; Kedem E; Katlama C; Sierra-Madero J; Afonso C; Brouwers P; Cooper DA;
    Clin Infect Dis; 2018 Jul; 67(3):420-429. PubMed ID: 29538636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial.
    Heemskerk D; Day J; Chau TT; Dung NH; Yen NT; Bang ND; Merson L; Olliaro P; Pouplin T; Caws M; Wolbers M; Farrar J
    Trials; 2011 Feb; 12():25. PubMed ID: 21288325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive Dexamethasone for Tuberculous Meningitis in HIV-Positive Adults.
    Donovan J; Bang ND; Imran D; Nghia HDT; Burhan E; Huong DTT; Hiep NTT; Ngoc LHB; Thanh DV; Thanh NT; Wardhani ALS; Maharani K; Gasmara CP; Hanh NHH; Oanh PKN; Estiasari R; Thu DDA; Kusumaningrum A; Dung LT; Giang DC; Ha DTM; Lan NH; Chau NVV; Nguyet NTM; Geskus RB; Thuong NTT; Kestelyn E; Hamers RL; Phu NH; Thwaites GE;
    N Engl J Med; 2023 Oct; 389(15):1357-1367. PubMed ID: 37819954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of punctuated antiretroviral therapy in Ugandan HIV-seropositive adults with pulmonary tuberculosis and CD4⁺ T-cell counts of ≥ 350 cells/μL.
    Nanteza MW; Mayanja-Kizza H; Charlebois E; Srikantiah P; Lin R; Mupere E; Mugyenyi P; Boom WH; Mugerwa RD; Havlir DV; Whalen CC
    J Infect Dis; 2011 Sep; 204(6):884-92. PubMed ID: 21849285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults.
    Thwaites GE; Nguyen DB; Nguyen HD; Hoang TQ; Do TT; Nguyen TC; Nguyen QH; Nguyen TT; Nguyen NH; Nguyen TN; Nguyen NL; Nguyen HD; Vu NT; Cao HH; Tran TH; Pham PM; Nguyen TD; Stepniewska K; White NJ; Tran TH; Farrar JJ
    N Engl J Med; 2004 Oct; 351(17):1741-51. PubMed ID: 15496623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults.
    Mai NTH; Dobbs N; Phu NH; Colas RA; Thao LTP; Thuong NTT; Nghia HDT; Hanh NHH; Hang NT; Heemskerk AD; Day JN; Ly L; Thu DDA; Merson L; Kestelyn E; Wolbers M; Geskus R; Summers D; Chau NVV; Dalli J; Thwaites GE
    Elife; 2018 Feb; 7():. PubMed ID: 29482717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis.
    Heemskerk AD; Bang ND; Mai NT; Chau TT; Phu NH; Loc PP; Chau NV; Hien TT; Dung NH; Lan NT; Lan NH; Lan NN; Phong le T; Vien NN; Hien NQ; Yen NT; Ha DT; Day JN; Caws M; Merson L; Thinh TT; Wolbers M; Thwaites GE; Farrar JJ
    N Engl J Med; 2016 Jan; 374(2):124-34. PubMed ID: 26760084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early versus delayed initiation of antiretroviral therapy for Indian HIV-Infected individuals with tuberculosis on antituberculosis treatment.
    Sinha S; Shekhar RC; Singh G; Shah N; Ahmad H; Kumar N; Sharma SK; Samantaray JC; Ranjan S; Ekka M; Sreenivas V; Mitsuyasu RT
    BMC Infect Dis; 2012 Jul; 12():168. PubMed ID: 22846195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial.
    Gulick RM; Ribaudo HJ; Shikuma CM; Lalama C; Schackman BR; Meyer WA; Acosta EP; Schouten J; Squires KE; Pilcher CD; Murphy RL; Koletar SL; Carlson M; Reichman RC; Bastow B; Klingman KL; Kuritzkes DR;
    JAMA; 2006 Aug; 296(7):769-81. PubMed ID: 16905783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of HIV type 1 infection: final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903.
    Berenguer J; González J; Ribera E; Domingo P; Santos J; Miralles P; Angels Ribas M; Asensi V; Gimeno JL; Pérez-Molina JA; Terrón JA; Santamaría JM; Pedrol E;
    Clin Infect Dis; 2008 Oct; 47(8):1083-92. PubMed ID: 18781872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of once-daily nevirapine- or efavirenz-based antiretroviral therapy in HIV-associated tuberculosis: a randomized clinical trial.
    Swaminathan S; Padmapriyadarsini C; Venkatesan P; Narendran G; Ramesh Kumar S; Iliayas S; Menon PA; Selvaraju S; Pooranagangadevi NP; Bhavani PK; Ponnuraja C; Dilip M; Ramachandran R
    Clin Infect Dis; 2011 Oct; 53(7):716-24. PubMed ID: 21890776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early antiretroviral therapy and mortality among HIV-infected infants.
    Violari A; Cotton MF; Gibb DM; Babiker AG; Steyn J; Madhi SA; Jean-Philippe P; McIntyre JA;
    N Engl J Med; 2008 Nov; 359(21):2233-44. PubMed ID: 19020325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa.
    Makadzange AT; Ndhlovu CE; Takarinda K; Reid M; Kurangwa M; Gona P; Hakim JG
    Clin Infect Dis; 2010 Jun; 50(11):1532-8. PubMed ID: 20415574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to initiate antiretroviral therapy between 4 weeks and 12 weeks of tuberculosis treatment in HIV-infected patients: results from the TIME study.
    Manosuthi W; Mankatitham W; Lueangniyomkul A; Thongyen S; Likanonsakul S; Suwanvattana P; Thawornwan U; Suntisuklappon B; Nilkamhang S; Sungkanuparph S;
    J Acquir Immune Defic Syndr; 2012 Aug; 60(4):377-83. PubMed ID: 22592586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lopinavir/ritonavir-based antiretroviral treatment (ART) versus efavirenz-based ART for the prevention of malaria among HIV-infected pregnant women.
    Natureeba P; Ades V; Luwedde F; Mwesigwa J; Plenty A; Okong P; Charlebois ED; Clark TD; Nzarubara B; Havlir DV; Achan J; Kamya MR; Cohan D; Dorsey G
    J Infect Dis; 2014 Dec; 210(12):1938-45. PubMed ID: 24958908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efavirenz versus boosted atazanavir or zidovudine and abacavir in antiretroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair study.
    Puls RL; Srasuebkul P; Petoumenos K; Boesecke C; Duncombe C; Belloso WH; Molina JM; Li L; Avihingsanon A; Gazzard B; Cooper DA; Emery S;
    Clin Infect Dis; 2010 Oct; 51(7):855-64. PubMed ID: 20735258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection.
    Robbins GK; De Gruttola V; Shafer RW; Smeaton LM; Snyder SW; Pettinelli C; Dubé MP; Fischl MA; Pollard RB; Delapenha R; Gedeon L; van der Horst C; Murphy RL; Becker MI; D'Aquila RT; Vella S; Merigan TC; Hirsch MS;
    N Engl J Med; 2003 Dec; 349(24):2293-303. PubMed ID: 14668455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal Trends in Co-trimoxazole Use Among Children on Antiretroviral Therapy and the Impact of Co-trimoxazole on Mortality Rates in Children Without Severe Immunodeficiency.
    Boettiger DC; Law MG; Sohn AH; Davies MA; Wools-Kaloustian K; Leroy V; Yotebieng M; Vinikoor M; Vreeman R; Amorissani-Folquet M; Edmonds A; Fatti G; Batte J; Renner L; Adedimeji A; Kariminia A;
    J Pediatric Infect Dis Soc; 2019 Nov; 8(5):450-460. PubMed ID: 30215763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.